Anixa Biosciences, Inc. (ANIX) vs Equillium, Inc. (EQ)
A side-by-side comparison of Anixa Biosciences, Inc. and Equillium, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANIX
Anixa Biosciences, Inc.
$3.03HealthcareDelayed quote: Oct 6, 2026, 11:34 AM EDT
EQ
Equillium, Inc.
$1.46HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT
Total return — ANIX vs EQ
growth of $100 · dividends reinvested · last 8yANIX -40.6% (-6.3%/yr)EQ -89.6% (-24.7%/yr)ANIX compounded faster over this window
Log scale — wide-divergence pair
ANIX EQ
ANIX vs EQ: by the numbers
- •ANIX is the larger company ($103M vs $92M market cap).
Metrics side by side
Valuation
| Metric | ANIX | EQ |
|---|---|---|
| P/B ratio | 7.12 | 1.65 |
Profitability
| Metric | ANIX | EQ |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -72.02% | -32.15% |
| ROIC | -82.35% | -34.10% |
Growth (annualized)
| Metric | ANIX | EQ |
|---|---|---|
| Total return CAGR (5Y) | -8.26% | -26.99% |
Frequently asked
- How have ANIX and EQ total returns compared?
- Over the past 5 years, ANIX delivered -8.26% and EQ delivered -26.99% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.